TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for ABCC2
check button Gene summary
Basic gene informationGene symbolABCC2
Gene nameATP-binding cassette, sub-family C (CFTR/MRP), member 2
SynonymsABC30|CMOAT|DJS|MRP2|cMRP
CytomapUCSC genome browser: 10q24
Type of geneprotein-coding
RefGenesNM_000392.4,
Descriptioncanalicular multidrug resistance proteincanalicular multispecific organic anion transporter 1multidrug resistance-associated protein 2
Modification date20141222
dbXrefs MIM : 601107
HGNC : HGNC
Ensembl : ENSG00000023839
HPRD : 03065
Vega : OTTHUMG00000018895
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ABCC2
BioGPS: 1244
PathwayNCI Pathway Interaction Database: ABCC2
KEGG: ABCC2
REACTOME: ABCC2
Pathway Commons: ABCC2
ContextiHOP: ABCC2
ligand binding site mutation search in PubMed: ABCC2
UCL Cancer Institute: ABCC2
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesTiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Liver
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)LIHC
Reference showing the relevant tissue of ABCC2
Description by TissGene annotations
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for ABCC2

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
COAD1.372416108-0.7345185072.1069346152.03E-058.62E-05
KICH-1.6656255842.504854416-4.170481.37E-098.34E-09
HNSC0.874690974-0.4689229791.3436139531.34E-057.37E-05
KIRC5.2763375833.4860681381.7902694442.17E-054.94E-05
LUAD0.65951014-0.8570743431.5165844830.000290.000677573


Top
TissGene-miRNA for ABCC2

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for ABCC2
TissGeneSNV for ABCC2

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.S650LUCEC2
p.R910CSKCM2
p.L64HHNSC1
p.K1329NPAAD1
p.L1507IBLCA1
p.L825IUCEC1
p.L49FREAD1
p.T486IUCEC1
p.E1538KCESC1
p.Y1529HBRCA1
p.S1168LSKCM1
p.A478VCOAD1
p.L783HSKCM1
p.G300RTHCA1
p.A1041SSTAD1
p.L367VUCEC1
p.V239LLIHC1
p.R934WUCEC1
p.S1367PUCS1
p.D1383ELUAD1
p.N1539ISKCM1
p.R100XREAD1
p.Q605HBRCA1
p.V545ASTAD1
p.G960VHNSC1
p.L1395FSTAD1
p.M432VUCEC1
p.K1288NBLCA1
p.I1512SCESC1
p.S211NSKCM1
p.T336MUCS1
p.R911*SKCM1
p.R815QUCEC1
p.G722RUCEC1
p.E896KSTAD1
p.A790SLUSC1
p.N193YESCA1
p.Q524KHNSC1
p.D304EUCEC1
p.K493NBLCA1
p.A364VSTAD1
p.Q488ELUAD1
p.L328PUCEC1
p.V1137IACC1
p.R1083WLUSC1
p.A350VESCA1
p.L834MUCEC1
p.L66IREAD1
p.D427ESKCM1
p.T838KKIRP1
p.L138ITHYM1
p.I178VUCEC1
p.R260WCOAD1
p.F1387LUCS1
p.R1100CCOAD1
p.A1420VLGG1
p.D883NUCEC1
p.E1411QBLCA1
p.A850VTHYM1
p.P1290STHYM1
p.L138FUCEC1
p.E228KHNSC1
p.A364VUCEC1
p.S978LUCEC1
p.E611KSKCM1
p.R1146CBRCA1
p.R911QCOAD1
p.D1287NHNSC1
p.R911*UCEC1
p.C166YSTAD1
p.G1510ESKCM1
p.D1014NSKCM1
p.K534NCOAD1
p.S594NLIHC1
p.P1283TLUSC1
p.A411TLGG1
p.V1188MSTAD1
p.G853RSKCM1
p.D1093NACC1
p.G1425WLUAD1
p.E969*STAD1
p.F1071CUCEC1
p.E1270DTHYM1
p.D792YHNSC1
p.L556MUCEC1
p.A850SREAD1
p.Q665HPAAD1
p.E1263*UCEC1
p.R655*SKCM1
p.K716NSTAD1
p.P597SSKCM1
p.V417ICOAD1
p.R1181XREAD1
p.R590HREAD1
p.R1174CBLCA1
p.R590HUCEC1
p.F909LUCEC1
p.S191*UCEC1
p.K530NCHOL1
p.E943KLUSC1
p.S582FSKCM1
p.R152WESCA1
p.E458QBLCA1
p.L931FBLCA1
p.V114IBLCA1
p.L138IUCEC1
p.C1105YBLCA1
p.K578TBLCA1
p.D1231GCOAD1
p.F586IREAD1
p.N527KSKCM1
p.R1210CUCEC1
p.I1133MUCEC1
p.A478VTGCT1
p.A985VUCEC1
p.R1349GUCEC1
p.K530NBRCA1
p.R260QBRCA1
p.K797TLUAD1
p.P1121TLUAD1
p.S601PBLCA1
p.R529LTHYM1
p.T1264ILUSC1
p.I1040TSTAD1
p.C385FLUAD1
p.I1190FTHCA1
p.P24QCHOL1
p.F1163LKIRP1
p.R353LESCA1
p.R628*UCEC1
p.R1374QREAD1
p.F855ISTAD1
p.A428DUCEC1
p.H923YSKCM1
p.T1004ISTAD1
p.W227XREAD1
p.S265FSKCM1
p.R1100CPAAD1
p.N937SLIHC1
p.R260WSTAD1
p.Q577HUCEC1
p.A1413SBLCA1
p.P1291LDLBC1
p.E224KUCS1
p.V305LLUAD1
p.L1246HLIHC1
p.R910HSTAD1
p.E943GLGG1
p.E969XSTAD1
p.L1386MSTAD1
p.K857NUCEC1
p.I448LUCEC1
p.L1370PKIRP1
p.R1079QPRAD1
p.D523EHNSC1
p.V1050FESCA1
p.L289MCESC1


Top
TissGeneCNV for ABCC2

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for ABCC2

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP
Chimerdb3.0ChiTaRsNACD358047SEPT7P2-ABCC2chr7:45806932chr10:101608951


Top
TissGeneNet for ABCC2

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (tumor)ABCC2, HNF4A, ONECUT1, NFKB1, PDZK1, SLC9A3R1, RDX, UBQLN1, AZIN1, HNF1A, CANX, PDZD3, MCPH1, IRF3, SHANK3 (normal)
bullet pointbullet point


Top
TissGeneProg for ABCC2

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for ABCC2
TissGeneDrug for ABCC2

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status
DB01138SulfinpyrazoneInhibitorSmall moleculeApproved
DB11256Levomefolic acidSmall moleculeApproved


Top
TissGeneDisease for ABCC2

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0022350Jaundice, Chronic Idiopathic32BeFree,CLINVAR,CTD_human,LHGDN,ORPHANET,RGD,UNIPROT
umls:C0014544Epilepsy17BeFree,GAD
umls:C0008370Cholestasis11BeFree,CTD_human,RGD
umls:C0268307Conjugated hyperbilirubinemia11BeFree
umls:C0020433Hyperbilirubinemia10BeFree,CTD_human,RGD
umls:C0029925Ovarian Carcinoma9BeFree
umls:C0006142Malignant neoplasm of breast8BeFree,GAD
umls:C0019693HIV Infections8BeFree,GAD
umls:C0677886Epithelial ovarian cancer8BeFree
umls:C2239176Liver carcinoma8BeFree
umls:C1527249Colorectal Cancer7BeFree,GAD
umls:C0242379Malignant neoplasm of lung6BeFree,GAD
umls:C0678222Breast Carcinoma6BeFree
umls:C0009402Colorectal Carcinoma5BeFree
umls:C0023530Leukopenia5BeFree,GAD
umls:C0027947Neutropenia5BeFree,GAD,LHGDN
umls:C0001418Adenocarcinoma4BeFree,GAD,LHGDN
umls:C0007131Non-Small Cell Lung Carcinoma4BeFree
umls:C0011991Diarrhea4BeFree,GAD
umls:C0023452Leukemia, Lymphocytic, Acute, L14BeFree
umls:C0268318Cholestasis of pregnancy4BeFree
umls:C0007134Renal Cell Carcinoma3BeFree
umls:C0009404Colorectal Neoplasms3CTD_human,GAD,LHGDN
umls:C0019158Hepatitis3BeFree
umls:C0019159Hepatitis A3BeFree
umls:C0041755Adverse reaction to drug3CTD_human
umls:C1140680Malignant neoplasm of ovary3BeFree,GAD
umls:C0003873Rheumatoid Arthritis2CTD_human,GAD
umls:C0008312Primary biliary cirrhosis2BeFree
umls:C0008372Intrahepatic Cholestasis2GAD,LHGDN
umls:C0009375Colonic Neoplasms2GAD,LHGDN
umls:C0011853Diabetes Mellitus, Experimental2RGD
umls:C0014547Epilepsies, Partial2BeFree
umls:C0015695Fatty Liver2GAD,RGD
umls:C0023895Liver diseases2BeFree,LHGDN
umls:C0025202melanoma2BeFree
umls:C0030297Pancreatic Neoplasm2GAD,LHGDN
umls:C0031117Peripheral Neuropathy2CTD_human,GAD
umls:C0032962Pregnancy Complications2GAD
umls:C0036572Seizures2BeFree,CTD_human
umls:C0079731B-Cell Lymphomas2BeFree
umls:C0149925Small cell carcinoma of lung2BeFree
umls:C0206698Cholangiocarcinoma2BeFree,GAD
umls:C0235974Pancreatic carcinoma2BeFree
umls:C0279626Squamous cell carcinoma of esophagus2BeFree,CTD_human
umls:C0346647Malignant neoplasm of pancreas2BeFree
umls:C0684249Carcinoma of lung2BeFree
umls:C0948380Colorectal cancer metastatic2BeFree
umls:C1168401Squamous cell carcinoma of the head and neck2BeFree,CTD_human
umls:C1378703Renal carcinoma2BeFree
umls:C0001430Adenoma1BeFree
umls:C0002170Alopecia1CTD_human
umls:C0005396Bile Duct Neoplasms1GAD
umls:C0005398Cholestasis, Extrahepatic1BeFree
umls:C0005684Malignant neoplasm of urinary bladder1GAD
umls:C0007137Squamous cell carcinoma1BeFree
umls:C0011860Diabetes Mellitus, Non-Insulin-Dependent1RGD
umls:C0013182Drug Allergy1CTD_human
umls:C0013221Drug toxicity1GAD
umls:C0014548Epilepsy, Generalized1BeFree
umls:C0016057Fibrosarcoma1BeFree
umls:C0017178Gastrointestinal Diseases1CTD_human
umls:C0018799Heart Diseases1CTD_human
umls:C0019193Hepatitis, Toxic1GAD
umls:C0019196Hepatitis C1BeFree
umls:C0022354Jaundice, Obstructive1BeFree
umls:C0022658Kidney Diseases1GAD
umls:C0022661Kidney Failure, Chronic1RGD
umls:C0023467Leukemia, Myelocytic, Acute1BeFree
umls:C0023473Myeloid Leukemia, Chronic1BeFree
umls:C0023474Leukemia, Myeloid, Chronic-Phase1GAD
umls:C0023892Biliary cirrhosis1CTD_human
umls:C0023903Liver neoplasms1BeFree
umls:C0024117Chronic Obstructive Airway Disease1GAD
umls:C0024121Lung Neoplasms1LHGDN
umls:C0024141Lupus Erythematosus, Systemic1LHGDN
umls:C0024299Lymphoma1BeFree
umls:C0025500Mesothelioma1BeFree
umls:C0027627Neoplasm Metastasis1BeFree
umls:C0027765nervous system disorder1CTD_human
umls:C0028754Obesity1BeFree
umls:C0028860Oculocerebrorenal Syndrome1BeFree
umls:C0030286Pancreatic Diseases1BeFree
umls:C0031048Pericarditis, Constrictive1BeFree
umls:C0033774Pruritus1GAD
umls:C0035078Kidney Failure1GAD
umls:C0036117Salmonella infections1BeFree
umls:C0038220Status Epilepticus1CTD_human,RGD
umls:C0042769Virus Diseases1BeFree
umls:C0080178Spina Bifida1BeFree,LHGDN
umls:C0086692Benign Neoplasm1BeFree
umls:C0149521Pancreatitis, Chronic1BeFree
umls:C0149958Complex partial seizures1BeFree
umls:C0151747Renal tubular disorder1BeFree
umls:C0153467Malignant tumor of peritoneum1BeFree
umls:C0206624Hepatoblastoma1BeFree
umls:C0206681Adenocarcinoma, Clear Cell1BeFree
umls:C0280220stage, ovarian epithelial cancer1BeFree
umls:C0345967Malignant mesothelioma1BeFree
umls:C0376544Hematopoietic Neoplasms1BeFree
umls:C0376618Endotoxemia1RGD
umls:C0400966Non-alcoholic Fatty Liver Disease1BeFree
umls:C0400979Obstruction of biliary tree1BeFree
umls:C0524910Hepatitis C, Chronic1BeFree
umls:C0596263Carcinogenesis1BeFree
umls:C0699791Stomach Carcinoma1BeFree
umls:C0740457Malignant neoplasm of kidney1BeFree
umls:C0860207Drug-Induced Liver Injury1CTD_human
umls:C0877382Delayed renal graft function1GAD
umls:C0948168Bone marrow toxicity1BeFree
umls:C1096063Drug Resistant Epilepsy1BeFree
umls:C1112160Gastrooesophageal cancer1BeFree
umls:C1302401Adenoma of large intestine1BeFree
umls:C1443924Severe diarrhea1BeFree
umls:C1458155Mammary Neoplasms1LHGDN
umls:C2931822Nasopharyngeal carcinoma1BeFree
umls:C2931852Clear-cell metastatic renal cell carcinoma1BeFree